US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 0.398
- +0.051+14.70%
Close Jul 12 16:00 ET
- 0.379
- -0.019-4.75%
Post 19:08 ET
10.07MMarket Cap-462P/E (TTM)
0.400High0.363Low140.87KVolume0.363Open0.347Pre Close53.97KTurnover0.63%Turnover RatioLossP/E (Static)25.31MShares1.15052wk High1.67P/B8.93MFloat Cap0.33352wk Low--Dividend TTM22.45MShs Float70042.500Historical High--Div YieldTTM10.58%Amplitude0.333Historical Low0.383Avg Price1Lot Size
About Traws Pharma Company
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Company Profile
SymbolTRAW
Company NameTraws Pharma
Listing DateJul 25, 2013
Founded1998
CEOMr. Werner Cautreels PhD
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address12 Penns Trail
CityNewtown
ProvincePennsylvania
CountryUnited States of America
Zip Code18940-3423
Phone1-267-759-3680
Websitehttp://www.onconova.com
Company Executives
- Name
- Position
- Salary
- Werner Cautreels PhD
- Director and Chief Executive Officer
- --
- Dr. Victor M. Moyo, M.D.
- Chief Medical Officer, Oncology
- 405.25K
- Charles David Pauza, PhD
- Chief Scientific Officer, Virology
- --
- Robert Redfield
- Chief Medical Officer
- --
- Nikolay Savchuk
- Director and Chief Operating Officer
- --
- Mark P. Guerin
- Chief Financial Officer and Principal Accounting Officer
- 745.52K
- Dr. Iain D. Dukes, D.Phil.
- Executive Chairman of the Board
- --
- Mary Teresa Shoemaker
- Independent Director
- 118.22K
- Jack E. Stover
- Independent Director
- 126.72K
- James J. Marino, J.D.,M.B.A.
- Independent Director
- 141.72K
- Dr. Trafford Clarke, PhD
- Independent Director
- 104.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
